Skip to main content
FDA Shortage Check

Is Cyanokit (Hydroxocobalamin Injection) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Cyanokit: in shortage (FDA, Oct 24)

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: mid-November 2026”. Manufacturer’s estimate, Teva Pharmaceuticals USA, Inc., Oct 15, 2026
DRUG
Cyanokit
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Nov 4, 2024
LAST FDA UPDATE
Oct 19, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 2 presentations: 1 unavailable · 1 limited · 0 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Hydroxocobalamin Injection. 2 presentations from 2 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

BTG International Inc.1 presentation · 1 limited

Contact (FDA's listing): 1 877 377 3784

  • 5 g/250mL

    Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11)

    Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage.

    NDC 50633-310-11Reverified

    Limited Availability

Teva Pharmaceuticals USA, Inc.1 presentation · 1 unavailable

Contact (FDA's listing): 800-545-8800

  • 1000 MCG/ML, 30 ML Multi-Dose Vial

    Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30)

    Estimated recovery: mid-November 2026

    NDC 0591-2888-30Reverified

    Unavailable

What the manufacturers told FDA

  • Teva Pharmaceuticals USA, Inc. · ‘Estimated recovery: mid-November 2026’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Cyanokit in shortage?
Yes. As of Oct 24, 2026, FDA lists Hydroxocobalamin Injection as currently in shortage: 2 presentations, 1 unavailable and 1 limited.
When will the Cyanokit shortage end?
FDA gives no end date. 1 presentation carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Cyanokit?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.